Scarica l'app Stockscreener
23.64
0.08%
0.02
Dopo l'orario di chiusura:
23.64
Precedente Chiudi:
$23.62
Aprire:
$23.54
Volume 24 ore:
517.89K
Relative Volume:
0.77
Capitalizzazione di mercato:
$2.85B
Reddito:
$1.72B
Utile/perdita netta:
$12.82M
Rapporto P/E:
236.40
EPS:
0.1
Flusso di cassa netto:
$98.59M
1 W Prestazione:
-1.58%
1M Prestazione:
-7.29%
6M Prestazione:
+21.60%
1 anno Prestazione:
+13.22%
Intervallo 1D:
$23.15
$23.89
Intervallo di 1 settimana:
$23.01
$24.11
Portata 52W:
$15.92
$26.04
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
23.64 | 2.85B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
237.17 | 38.50B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
76.31 | 13.20B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
62.69 | 11.76B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
48.03 | 8.27B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.32 | 7.31B | 1.15B | 96.70M | -161.99M | 1.09 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Charles Schwab Investment Management Inc. Has $22.17 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Atria Investments Inc Has $274,000 Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
This Insider Has Just Sold Shares In Privia Health Group - Simply Wall St
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Victory Capital Management Inc. - Defense World
Privia Health group CEO Parth Mehrotra sells $252,651 in stock - Investing.com
Privia Health group CEO Parth Mehrotra sells $252,651 in stock By Investing.com - Investing.com Australia
US Bancorp DE Buys 1,134 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health CFO David Mountcastle sells $141,658 in stock By Investing.com - Investing.com South Africa
Privia Health EVP Fargis Edward C sells shares worth $120,255 By Investing.com - Investing.com Canada
Top Executives at Privia Health Group Cash Out on Stock Sales - TipRanks
Privia Health EVP Fargis Edward C sells shares worth $120,255 - Investing.com India
Privia Health CFO David Mountcastle sells $141,658 in stock - Investing.com
Privia Health Group Executives Sell Shares to Cover Tax Obligations - TradingView
Privia Health Group Executives Sell Shares for Tax Obligations - TradingView
Proficio Capital Partners LLC Invests $464,000 in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
PRVA Shares Experience Decline in Value - Knox Daily
Privia Health adjusts executive pay structure By Investing.com - Investing.com South Africa
Privia Health adjusts executive pay structure - Investing.com India
Bank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Jefferies raises Privia Health stock price target to $29 - Investing.com India
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 - MSN
When Should You Buy Privia Health Group, Inc. (NASDAQ:PRVA)? - Yahoo Finance UK
Leerink Partnrs Has Pessimistic View of PRVA Q1 Earnings - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $30.00 - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 - Defense World
Canaccord lifts Privia Health stock target to $30, maintains Buy - Investing.com
Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $25.19 - MarketBeat
Versor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2024 Earnings Call Transcript - MSN
JMP raises Privia Health stock target to $29 on strong outlook - Investing.com Canada
Privia Health Group Reports Strong 2024 Financial Results - TipRanks
Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Taking on analysts’ expectations and winning: Privia Health Group Inc (PRVA) - SETE News
Truist Adjusts Price Target on Privia Health Group to $30 From $27, Maintains Buy Rating - Marketscreener.com
UBS Adjusts Price Target on Privia Health Group to $31 From $27, Keeps Buy Rating - Marketscreener.com
JMP raises Privia Health stock target to $29 on strong outlook By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - The Herald Review
Rhumbline Advisers Grows Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group’s Strong Performance and Promising Outlook Justifies Buy Rating - TipRanks
Privia Health’s 2024 Earnings Call Highlights Growth - TipRanks
Citi raises Privia Health target to $32, maintains Buy rating By Investing.com - Investing.com Australia
Piper Sandler raises Privia Health stock target to $40 By Investing.com - Investing.com Canada
Piper Sandler raises Privia Health stock target to $40 - Investing.com India
Privia Health stock target raised to $30 by TD Cowen - Investing.com Canada
Earnings call transcript: Privia Health Q4 2024 beats earnings forecast By Investing.com - Investing.com Canada
Citi raises Privia Health target to $32, maintains Buy rating - Investing.com India
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.50%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):